Table 2 Association of clinical and pathological characteristics with GPNMB expression in 98 patients with TNBC.

From: Expression pattern and prognostic impact of glycoprotein non-metastatic B (GPNMB) in triple-negative breast cancer

Characteristics

Number of patients (n = 98)

GPNMB expression

P-value

Low (n = 44)

High (n = 54)

Age

 ≤ 60

60

24 (54.5)

36 (66.7)

0.221

 > 60

38

20 (45.5)

18 (33.3)

 

Tumor stage

Tis

1

0 (0)

1 (1.9)

0.530

T1

31

13 (29.5)

18 (33.3)

 

T2

59

28 (63.6)

31 (57.4)

 

T3

2

0 (0)

2 (3.7)

 

T4

5

3 (6.8)

2 (3.7)

 

Nodal status

N0

56

27 (61.4)

29 (53.7)

0.558

N1

22

8 (18.2)

14 (25.9)

 

N2

7

2 (4.5)

5 (9.3)

 

N3

13

7 (15.9)

6 (11.1)

 

TNM stage

DCIS + I + II

75

33 (75.0)

42 (77.8)

0.813

III

23

11 (25.0)

11 (22.2)

 

Grade

1 + 2

36

8 (18.2)

28 (51.9)

0.001

3

62

36 (81.8)

26 (48.1)

 

Lymphovascular invasion

Absent

76

31 (72.1)

45 (83.3)

0.182

Present

21

12 (27.9)

9 (16.7)

 

NAa

1

   

Tumor necrosis

Absent

41

20 (45.5)

21 (38.9)

0.512

Present

57

24 (54.5)

33 (61.1)

 
  1. aNA, not available.